Actively Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Led by Replimune, Inc. · Updated on 2026-01-12
50
Participants Needed
2
Research Sites
520 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a noninterventional, observational, long-term follow-up (LTFU) study. Patients in this study will be followed for 5 years from enrollment on this study to assess potential delayed risks of RPx products. Eligible participants for this LTFU study include patients who received at least 1 dose of an RPx product under the interventional parent study. Patients will be rolled over into this LTFU study after completion of the Replimune-sponsored parent study (ie, either completion of the LTFU in the parent study or withdrawal from the parent study). All patients in ongoing RPx studies will be asked to participate in this LTFU study so that the Sponsor can evaluate potential delayed risks.
CONDITIONS
Official Title
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Who Can Participate
Eligibility Criteria
You may qualify if you...
Patients are eligible for inclusion in the study only if they meet all of the following criteria:
- Patient has received at least 1 dose of an RPx product and has completed or discontinued participation in the parent study.
- Patient or patient's legal guardian has provided signed informed consent (or assent) as , which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.
You will not qualify if you...
Patients are excluded from the study if the following criterion applies:
1. Cannot comply with the requirements of the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
UC San Diego Moores Cancer Center
La Jolla, California, United States, 92093-0698
Actively Recruiting
2
Tasman Oncology Research
Southport, Queensland, Australia, 4215
Actively Recruiting
Research Team
C
Clinical Trials at Replimune
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here